Large US trial supports silver diamine fluoride for severe early childhood caries
A large US trial reveals how a quick, noninvasive dental treatment could help manage aggressive tooth decay in…
Dual immunotherapy with neoadjuvant chemotherapy shows encouraging activity in ERBB2-negative breast cancer
A combination of two immunotherapy drugs showed encouraging activity when added to standard chemotherapy given prior to surgery…
New strategy combines cancer immunotherapy and gene therapy in a single nanoparticle
Cancer cells survive by hiding from the immune system’s surveillance. A KAIST research team has developed a new…
Gut microbial metabolites may shape vulnerability to stress-related mental disorders
Jul 20 2026 From short-chain fatty acids to bile acids, researchers trace how microbial chemistry could influence brain…
KAIST study opens a new avenue for treating intractable brain tumors
Researchers have uncovered a clue to why immune checkpoint inhibitors-cancer therapies that release the immune “brakes” exploited by…
Political polarization drives surge in anti-vaccine legislation across the US
Despite overwhelming evidence on the safety and efficacy of COVID-19 vaccines, vaccine hesitancy intensified during the COVID-19 pandemic…
Nearly one in 10 Britons use or want weight-loss medication
A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
Weill Cornell Medicine receives federal grant to study new gene therapy for Alzheimer’s disease
The National Institute on Aging of the National Institutes of Health has awarded a five-year grant initially worth…
Researchers identify brain circuits responsible for triggering OCD symptoms
Most of the time, the origin of obsessive-compulsive disorder (OCD) is unknown, but in some rare cases, it…
Low-cost B-cell depleting therapy is as effective as standard treatment for multiple sclerosis
A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a…
Targeted therapy doubles progression-free survival in rare bile duct cancer
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid…
Smart prodrug targets Alzheimer’s disease using hydrogen peroxide signals
A substance that worsens dementia has become a “switch” that initiates treatment. KAIST researchers have developed a new…